Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent <i>in vivo</i> antitumor activity

Sauveur-Michel Maira, Carlos García-Echeverría, Doriano Fabbro et al.|Molecular Cancer Therapeutics|2008

Cited by 1.1k